Why the study?
Information on the safety and efficacy of regional anesthesia in patients with Brugada syndrome is limited.
Are lower extremity peripheral nerve blocks with low-dose ropivacaine safe and effective for post-operative pain control in a patient with Brugada syndrome?
Are lower extremity peripheral nerve blocks with low-dose ropivacaine safe and effective for post-operative pain control in a patient with Brugada syndrome?
Low-dose ropivacaine for peripheral nerve blocks was safely used without triggering arrhythmias or EKG changes in a patient with Brugada syndrome.
Supports cautious regional anesthesia in Brugada syndrome; hypothesis-generating and requires prospective validation.
We describe the case of a 28-year-old man with Brugada syndrome who received single-shot adductor canal and sciatic nerve blocks for the management of post-operative pain related to extensive orthopedic injuries. Low-dose ropivacaine with glucocorticoid additives was administered without any EKG changes, arrhythmias, or syncopal sensations. The patient experienced pain relief for over 24 h and was monitored on telemetry with defibrillator pads as a cardiac precaution. This case adds a valuable data point in the limited canon of information on the safety and efficacy of regional anesthesia in Brugada syndrome for the perioperative physician.
No takes yet. Share an insight, caveat, or question.
Bergbower et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: